SARS-CoV-2 Testing
Accelero receives authority permit for SARS-CoV-2 testing. Please read the complete press release here.
Accelero bietet Gesundheitsämtern in Deutschland eine Unterstützung bei der SARS-CoV-2 Probenanalyse an.
Accelero Receives Authority Permit for SARS-CoV-2 Testing
Berlin, 23 March 2020
Accelero Bioanalytics GmbH (“Accelero”) has received the authority permit for processing and analysis of SARS-CoV-2 in biological samples.
